Related Experiment Videos
[Systemic therapy of diffuse effluvium and hair structure damage]
J Budde1, H Tronnier, V W Rahlfs
1Hautärztliche Praxis, Marl.
Summary
This study found that a vitamin B-group and L-cystine treatment (active medication 1) significantly improved hair quality and growth compared to placebo. Another formulation (active medication 2) showed moderate benefits, with no adverse effects observed.
Area of Science:
- Dermatology
- Trichology
- Pharmacology
Background:
- Diffuse hair effluvium and structural lesions are common concerns.
- Assessing therapeutic interventions for hair loss requires robust methodologies.
Purpose of the Study:
- To compare the efficacy and tolerance of two formulations of B-group vitamins and L-cystine against a placebo.
- To evaluate the impact of specific active ingredients on hair quality and growth.
Main Methods:
- A controlled, randomized, double-blind study involving 72 female patients.
- Assessment of hair quality (swelling) and hair growth (anagen rates via trichogram) before and after 4 months of treatment.
- Comparison of two active medications with different compositions against a placebo.
Main Results:
- Active medication 1 demonstrated statistically significant superiority over placebo in improving hair quality and growth.
- Active medication 2 showed improvement compared to placebo but was less effective than active medication 1.
- Additional ingredients in active medication 1, not present in active medication 2, were key to its enhanced efficacy.
Conclusions:
- The tested therapeutic agents containing B-group vitamins and L-cystine are well-tolerated for hair loss treatment.
- Formulation composition, beyond L-cystine concentration, significantly influences treatment efficacy.
- Active medication 1 represents a more effective therapeutic option for diffuse hair effluvium and structural lesions.